Wave Life Sciences files Form 8-K
Wave Life Sciences filed a Form 8-K on October 27.
Related stories
Monro reports second-quarter loss per share
M impact | EQUITY | Oct 29, 2026, 11:43 AM UTC
APi Group Reports Record Q3 Results, Raises 2026 Outlook
APi Group reported financial results for the three and nine months ended September 30, 2026, and raised its full-year 2026 outlook.
M impact | EQUITY | Oct 29, 2026, 11:43 AM UTC
EMCOR Group Reports Record Third-Quarter 2026 Results
EMCOR reported quarterly record revenue of $5.54 billion, up 28.8% from $4.30 billion a year earlier.
M impact | EQUITY | Oct 29, 2026, 11:34 AM UTC
Belden Reports Third-Quarter Revenue of $966 Million
M impact | EQUITY | Oct 29, 2026, 11:30 AM UTC
Cheniere Reports Q3 Results, Raises 2026 Guidance and Dividend
Cheniere reported third-quarter 2026 financial results, raised its full-year 2026 financial guidance and increased its quarterly dividend by over 12%.
M impact | EQUITY | Oct 29, 2026, 11:30 AM UTC
Monro Reports Second-Quarter Fiscal 2027 Financial Results
Sales decreased 1.8% in the quarter ended September 26, 2026.
M impact | EQUITY | Oct 29, 2026, 11:30 AM UTC